
Sophia S. Chen
Examiner (ID: 12715, Phone: (571)272-2133 , Office: P/2852 )
| Most Active Art Unit | 2852 |
| Art Unit(s) | 2809, 2105, 2852 |
| Total Applications | 3640 |
| Issued Applications | 3462 |
| Pending Applications | 93 |
| Abandoned Applications | 111 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9462822
[patent_doc_number] => 20140127249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'INFLUENZA VIRUS MUTANTS AND USES THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/128415
[patent_app_country] => US
[patent_app_date] => 2012-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 31574
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128415
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/128415 | Influenza virus mutants and uses therefor | Jun 20, 2012 | Issued |
Array
(
[id] => 9817188
[patent_doc_number] => 08926971
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-06
[patent_title] => 'Humanized anti-CCR2 antibodies and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 13/528407
[patent_app_country] => US
[patent_app_date] => 2012-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 65
[patent_no_of_words] => 35259
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528407
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/528407 | Humanized anti-CCR2 antibodies and methods of use therefor | Jun 19, 2012 | Issued |
Array
(
[id] => 9596770
[patent_doc_number] => 20140193450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'PEPTIDE CARRIER FUSION PROTEINS AS ALLERGY VACCINES'
[patent_app_type] => utility
[patent_app_number] => 14/124925
[patent_app_country] => US
[patent_app_date] => 2012-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 29072
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124925
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124925 | Peptide carrier fusion proteins as allergy vaccines | Jun 10, 2012 | Issued |
Array
(
[id] => 9691301
[patent_doc_number] => 08821891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-02
[patent_title] => 'Live attenuated rotavirus vaccine for oral administration'
[patent_app_type] => utility
[patent_app_number] => 13/486039
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 32293
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13486039
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/486039 | Live attenuated rotavirus vaccine for oral administration | May 31, 2012 | Issued |
Array
(
[id] => 11304800
[patent_doc_number] => 09512185
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof'
[patent_app_type] => utility
[patent_app_number] => 14/123305
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 38
[patent_no_of_words] => 16584
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123305
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/123305 | Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof | May 31, 2012 | Issued |
Array
(
[id] => 11304798
[patent_doc_number] => 09512184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Hepatitis C virus particles, vaccines, compositions and methods related thereto'
[patent_app_type] => utility
[patent_app_number] => 14/118855
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 14644
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118855
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118855 | Hepatitis C virus particles, vaccines, compositions and methods related thereto | May 17, 2012 | Issued |
Array
(
[id] => 8464717
[patent_doc_number] => 20120269885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'Vaccine for Modulating Between T1 and T2 Immune Responses'
[patent_app_type] => utility
[patent_app_number] => 13/462356
[patent_app_country] => US
[patent_app_date] => 2012-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8764
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462356
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/462356 | Vaccine for Modulating Between T1 and T2 Immune Responses | May 1, 2012 | Abandoned |
Array
(
[id] => 8464716
[patent_doc_number] => 20120269884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'Vaccine for Modulating Between T1 and T2 Immune Responses'
[patent_app_type] => utility
[patent_app_number] => 13/462314
[patent_app_country] => US
[patent_app_date] => 2012-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8763
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462314
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/462314 | Vaccine for modulating between T1 and T2 immune responses | May 1, 2012 | Issued |
Array
(
[id] => 10863457
[patent_doc_number] => 08889147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'DNA vaccine against multitypes of avian influenza viruses and influenza virus-like particles comprising adjuvant-fused M2 protein'
[patent_app_type] => utility
[patent_app_number] => 13/449654
[patent_app_country] => US
[patent_app_date] => 2012-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 20
[patent_no_of_words] => 7596
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13449654
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/449654 | DNA vaccine against multitypes of avian influenza viruses and influenza virus-like particles comprising adjuvant-fused M2 protein | Apr 17, 2012 | Issued |
Array
(
[id] => 9435047
[patent_doc_number] => 20140112954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'METHOD FOR PREPARING HBV VACCINE COMPRISING ALUMINUM ADJUVANT'
[patent_app_type] => utility
[patent_app_number] => 14/117937
[patent_app_country] => US
[patent_app_date] => 2012-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5327
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117937
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/117937 | METHOD FOR PREPARING HBV VACCINE COMPRISING ALUMINUM ADJUVANT | Apr 17, 2012 | Abandoned |
Array
(
[id] => 11583131
[patent_doc_number] => 09637758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Modified Sendai virus vaccine and imaging vector'
[patent_app_type] => utility
[patent_app_number] => 14/113769
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 26
[patent_no_of_words] => 30031
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113769
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113769 | Modified Sendai virus vaccine and imaging vector | Apr 12, 2012 | Issued |
Array
(
[id] => 9408083
[patent_doc_number] => 20140099335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'DNA VACCINE'
[patent_app_type] => utility
[patent_app_number] => 14/111699
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9447
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111699
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/111699 | DNA vaccine | Apr 12, 2012 | Issued |
Array
(
[id] => 9476741
[patent_doc_number] => 20140134204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'METHODS OF IMPROVING VACCINE IMMUNOGENICITY'
[patent_app_type] => utility
[patent_app_number] => 14/110101
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21580
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110101
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110101 | Methods of improving vaccine immunogenicity | Apr 3, 2012 | Issued |
Array
(
[id] => 9482774
[patent_doc_number] => 08728723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-20
[patent_title] => 'Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism'
[patent_app_type] => utility
[patent_app_number] => 13/435325
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 17444
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13435325
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/435325 | Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism | Mar 29, 2012 | Issued |
Array
(
[id] => 9476743
[patent_doc_number] => 20140134206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'INFLAMMATION AND IMMUNITY TREATMENTS'
[patent_app_type] => utility
[patent_app_number] => 14/008995
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9929
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008995
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008995 | Inflammation and immunity treatments | Mar 29, 2012 | Issued |
Array
(
[id] => 8885049
[patent_doc_number] => 20130158233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'METHOD FOR SIMULTANEOUSLY DETECTING AN ANTIGEN OF, AND AN ANTIBODY, AGAINST, AN INFECTIOUS MICROORGANISM'
[patent_app_type] => utility
[patent_app_number] => 13/435381
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17378
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13435381
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/435381 | Method for simultaneously detecting an antigen of, and an antibody, against, an infectious microorganism | Mar 29, 2012 | Issued |
Array
(
[id] => 8453163
[patent_doc_number] => 20120264109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'LYMPHOCYTE ANALYSIS FOR MONITORING THE PROGRESSION OF IMMUNODEFICIENCY VIRUS'
[patent_app_type] => utility
[patent_app_number] => 13/432542
[patent_app_country] => US
[patent_app_date] => 2012-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4023
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13432542
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/432542 | LYMPHOCYTE ANALYSIS FOR MONITORING THE PROGRESSION OF IMMUNODEFICIENCY VIRUS | Mar 27, 2012 | Abandoned |
Array
(
[id] => 9197614
[patent_doc_number] => 20130336929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'METHODS AND CELLS FOR IDENTIFYING RIG-I PATHWAY REGULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/001472
[patent_app_country] => US
[patent_app_date] => 2012-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17815
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001472
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/001472 | Methods and cells for identifying RIG-I pathway regulators | Feb 22, 2012 | Issued |
Array
(
[id] => 11794129
[patent_doc_number] => 09403879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same'
[patent_app_type] => utility
[patent_app_number] => 13/984771
[patent_app_country] => US
[patent_app_date] => 2012-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 20
[patent_no_of_words] => 14475
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984771
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/984771 | Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same | Feb 12, 2012 | Issued |
Array
(
[id] => 10850527
[patent_doc_number] => 08877205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-04
[patent_title] => 'Yeast-based therapeutic for chronic hepatitis B infection'
[patent_app_type] => utility
[patent_app_number] => 13/984888
[patent_app_country] => US
[patent_app_date] => 2012-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 42
[patent_no_of_words] => 96296
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984888
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/984888 | Yeast-based therapeutic for chronic hepatitis B infection | Feb 8, 2012 | Issued |